Literature DB >> 30409320

A gene expression profile associated with perineural invasion identifies a subset of HNSCC at risk of post-surgical recurrence.

Zuzana Saidak1, Florian Clatot2, Denis Chatelain3, Antoine Galmiche4.   

Abstract

OBJECTIVES: Perineural invasion (PNI) is a common histopathological finding in head and neck squamous cell carcinoma (HNSCC). We aimed to explore the molecular mechanisms involved in PNI and the role of PNI as an aggressive pathological feature.
MATERIALS AND METHODS: We used data from The Cancer Genome Atlas (TCGA) to relate the histological presentation of 528 HNSCC tumours to clinical, whole genome expression and proteomic data.
RESULTS: We identified a specific gene expression profile highly enriched in genes related to muscle differentiation/function and associated with PNI in HNSCC. We explored the clinical significance of this profile in three groups of HNSCC tumours stratified according to their low, intermediate or high risk of post-surgical recurrence. In the "low-risk" group, defined as tumours indicated for surgery without adjuvant radiotherapy (n = 51), the PNI gene expression profile identified a subset of HNSCC with a higher rate of tumour recurrence, decreased Disease Free Survival (DFS) and Overall Survival (OS) (p < 0.0001 and p = 0.0064, respectively). Comparable results were observed in "intermediate risk" tumours (n = 112), but not in "high risk" tumours (n = 147), whose prognosis was driven by the presence of lymph node extracapsular spread. Finally, we found that tumours with histological PNI had increased activation levels of the Akt/PKB and mTOR (mammalian Target Of Rapamycin) kinases.
CONCLUSION: PNI is characterised by a specific gene expression profile and distinct biological characteristics. Analysing the PNI gene expression profile holds potential for therapeutic stratification of HNSCC and identification of a subset of tumours with a higher risk of recurrence.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gene expression; Head and neck squamous cell carcinoma; Perineural invasion; The Cancer Genome Atlas (TCGA)

Year:  2018        PMID: 30409320     DOI: 10.1016/j.oraloncology.2018.09.005

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  5 in total

1.  Interobserver Variation in Evaluating Perineural Invasion for Oral Squamous Cell Carcinoma: Phase 2 Survey Study.

Authors:  Flora Yan; Yi-Shing Lisa Cheng; Nora Katabi; Shaun A Nguyen; Huey-Shys Chen; Patrick Morgan; Kathy Zhang; Angela C Chi
Journal:  Head Neck Pathol       Date:  2021-03-31

Review 2.  The Microenvironment of Tongue Cancer.

Authors:  Want Tao; Zeng Li-Juan; Li Kan; Li Jing-Yuan; Liu Xiang-Qi; Liang Yu-Jie
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

3.  Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma.

Authors:  Ming-Huei Chou; Hui-Ching Chuang; Yu-Tsai Lin; Ming-Hsien Tsai; Ying-Hsien Kao; I-Chun Lin; Tai-Lin Huang; Fu-Min Fang; Chih-Yen Chien
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

Review 4.  Contribution of Genomics to the Surgical Management and Study of Oral Cancer.

Authors:  Zuzana Saidak; Claire Lailler; Sylvie Testelin; Bruno Chauffert; Florian Clatot; Antoine Galmiche
Journal:  Ann Surg Oncol       Date:  2021-04-12       Impact factor: 5.344

5.  A six-gene expression signature related to angiolymphatic invasion is associated with poor survival in laryngeal squamous cell carcinoma.

Authors:  Jochen Hess; Dominik Horn; Karl Metzger; Julius Moratin; Kolja Freier; Jürgen Hoffmann; Karim Zaoui; Michaela Plath; Fabian Stögbauer; Christian Freudlsperger
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-07-20       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.